 Robin Shandas
Concepts (370)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Models, Cardiovascular | 32 | 2016 | 179 | 3.720 |
Why?
| | Pulmonary Artery | 26 | 2016 | 1024 | 3.370 |
Why?
| | Hypertension, Pulmonary | 24 | 2017 | 1736 | 2.490 |
Why?
| | Ultrasonography | 15 | 2017 | 635 | 2.480 |
Why?
| | Rheology | 9 | 2018 | 86 | 2.020 |
Why?
| | Microbubbles | 12 | 2013 | 40 | 1.890 |
Why?
| | Blood Flow Velocity | 24 | 2018 | 387 | 1.870 |
Why?
| | Pulmonary Circulation | 10 | 2017 | 407 | 1.840 |
Why?
| | Image Interpretation, Computer-Assisted | 9 | 2016 | 225 | 1.460 |
Why?
| | Vascular Resistance | 8 | 2017 | 340 | 1.320 |
Why?
| | Hemorheology | 9 | 2005 | 20 | 1.090 |
Why?
| | Carotid Arteries | 5 | 2017 | 180 | 1.080 |
Why?
| | Contrast Media | 8 | 2017 | 347 | 1.020 |
Why?
| | Ultrasonography, Doppler | 4 | 2018 | 104 | 0.930 |
Why?
| | Algorithms | 8 | 2016 | 1469 | 0.900 |
Why?
| | Hemodynamics | 9 | 2017 | 1015 | 0.900 |
Why?
| | Blood Pressure | 14 | 2016 | 1531 | 0.900 |
Why?
| | Surgical Mesh | 2 | 2013 | 40 | 0.840 |
Why?
| | Fontan Procedure | 7 | 2009 | 168 | 0.830 |
Why?
| | Computer Simulation | 18 | 2018 | 873 | 0.810 |
Why?
| | Polymers | 7 | 2018 | 448 | 0.760 |
Why?
| | Materials Testing | 6 | 2019 | 337 | 0.760 |
Why?
| | Echocardiography, Doppler | 5 | 2006 | 95 | 0.730 |
Why?
| | Heart Ventricles | 5 | 2016 | 723 | 0.680 |
Why?
| | Arteries | 6 | 2013 | 246 | 0.670 |
Why?
| | Models, Biological | 7 | 2011 | 1611 | 0.660 |
Why?
| | Stress, Mechanical | 14 | 2018 | 445 | 0.650 |
Why?
| | Laparoscopy | 2 | 2013 | 395 | 0.640 |
Why?
| | Image Enhancement | 3 | 2009 | 158 | 0.600 |
Why?
| | Carotid Artery, Common | 1 | 2018 | 29 | 0.590 |
Why?
| | Image Processing, Computer-Assisted | 5 | 2017 | 684 | 0.580 |
Why?
| | Blood Pressure Determination | 3 | 2008 | 122 | 0.570 |
Why?
| | Models, Theoretical | 7 | 2013 | 513 | 0.570 |
Why?
| | Transducers | 2 | 2009 | 24 | 0.550 |
Why?
| | Patient-Specific Modeling | 1 | 2016 | 37 | 0.540 |
Why?
| | Imaging, Three-Dimensional | 5 | 2013 | 511 | 0.530 |
Why?
| | Heart Defects, Congenital | 5 | 2007 | 685 | 0.530 |
Why?
| | Compliance | 4 | 2011 | 46 | 0.500 |
Why?
| | Ultrasonics | 3 | 2013 | 46 | 0.500 |
Why?
| | Elasticity | 10 | 2015 | 188 | 0.470 |
Why?
| | Vascular Endothelial Growth Factor A | 5 | 2022 | 496 | 0.460 |
Why?
| | Elastic Modulus | 3 | 2013 | 116 | 0.440 |
Why?
| | Hernia, Ventral | 1 | 2013 | 18 | 0.440 |
Why?
| | Polyesters | 1 | 2013 | 64 | 0.430 |
Why?
| | Reproducibility of Results | 10 | 2018 | 2764 | 0.430 |
Why?
| | Ventricular Function, Right | 4 | 2017 | 256 | 0.420 |
Why?
| | Ventricular Dysfunction, Right | 3 | 2015 | 221 | 0.420 |
Why?
| | Magnetic Resonance Imaging | 4 | 2017 | 3039 | 0.420 |
Why?
| | Biocompatible Materials | 3 | 2013 | 372 | 0.420 |
Why?
| | Vasodilator Agents | 2 | 2011 | 302 | 0.400 |
Why?
| | Heart-Assist Devices | 2 | 2009 | 500 | 0.390 |
Why?
| | Elastin | 2 | 2011 | 78 | 0.390 |
Why?
| | Equipment Failure Analysis | 5 | 2013 | 132 | 0.390 |
Why?
| | Cattle | 11 | 2017 | 918 | 0.380 |
Why?
| | Models, Anatomic | 3 | 2018 | 86 | 0.380 |
Why?
| | Vascular Stiffness | 6 | 2017 | 410 | 0.370 |
Why?
| | MicroRNAs | 1 | 2017 | 600 | 0.370 |
Why?
| | Heart Bypass, Right | 3 | 2006 | 17 | 0.370 |
Why?
| | Myocardial Perfusion Imaging | 1 | 2011 | 34 | 0.360 |
Why?
| | Ventricular Function, Left | 3 | 2004 | 477 | 0.360 |
Why?
| | Ultrasonography, Doppler, Pulsed | 1 | 2010 | 6 | 0.350 |
Why?
| | Uncertainty | 1 | 2010 | 91 | 0.330 |
Why?
| | Shear Strength | 5 | 2017 | 65 | 0.330 |
Why?
| | Animals | 31 | 2022 | 31570 | 0.330 |
Why?
| | Micro-Electrical-Mechanical Systems | 1 | 2009 | 5 | 0.330 |
Why?
| | Numerical Analysis, Computer-Assisted | 4 | 2004 | 17 | 0.320 |
Why?
| | Child | 19 | 2018 | 18408 | 0.310 |
Why?
| | Miniaturization | 2 | 2009 | 23 | 0.310 |
Why?
| | Humans | 53 | 2018 | 114080 | 0.300 |
Why?
| | Tissue Scaffolds | 3 | 2019 | 179 | 0.290 |
Why?
| | Laser-Doppler Flowmetry | 2 | 2004 | 32 | 0.290 |
Why?
| | Aortic Valve | 2 | 2009 | 397 | 0.280 |
Why?
| | Biomarkers | 1 | 2017 | 3397 | 0.280 |
Why?
| | Phantoms, Imaging | 4 | 2014 | 123 | 0.280 |
Why?
| | Myocytes, Smooth Muscle | 3 | 2017 | 236 | 0.280 |
Why?
| | Lung | 4 | 2013 | 3521 | 0.270 |
Why?
| | Child, Preschool | 15 | 2017 | 9121 | 0.270 |
Why?
| | Heart Septal Defects | 1 | 2006 | 10 | 0.270 |
Why?
| | Gels | 2 | 2018 | 72 | 0.270 |
Why?
| | Vasomotor System | 1 | 2006 | 39 | 0.260 |
Why?
| | Male | 24 | 2018 | 55420 | 0.260 |
Why?
| | Pulsatile Flow | 6 | 2012 | 54 | 0.260 |
Why?
| | Sensitivity and Specificity | 7 | 2016 | 1690 | 0.260 |
Why?
| | In Vitro Techniques | 6 | 2012 | 1003 | 0.250 |
Why?
| | Magnetic Resonance Imaging, Cine | 2 | 2017 | 172 | 0.250 |
Why?
| | Female | 23 | 2018 | 59349 | 0.250 |
Why?
| | Myocytes, Cardiac | 3 | 2019 | 449 | 0.250 |
Why?
| | Tissue Engineering | 3 | 2019 | 364 | 0.250 |
Why?
| | Hypoxia | 1 | 2011 | 956 | 0.240 |
Why?
| | Reference Values | 4 | 2018 | 739 | 0.240 |
Why?
| | Scattering, Radiation | 4 | 2006 | 94 | 0.240 |
Why?
| | Rats, Sprague-Dawley | 6 | 2019 | 2182 | 0.240 |
Why?
| | Linear Models | 3 | 2007 | 768 | 0.230 |
Why?
| | Cardiovascular System | 2 | 2006 | 126 | 0.230 |
Why?
| | Diagnosis, Computer-Assisted | 2 | 2005 | 64 | 0.230 |
Why?
| | Stroke Volume | 2 | 2017 | 513 | 0.230 |
Why?
| | Rats | 7 | 2019 | 4913 | 0.230 |
Why?
| | Connective Tissue | 1 | 2004 | 36 | 0.220 |
Why?
| | Aorta | 2 | 2005 | 388 | 0.220 |
Why?
| | Ventricular Function | 1 | 2004 | 57 | 0.220 |
Why?
| | Physical Stimulation | 1 | 2004 | 76 | 0.220 |
Why?
| | Energy Transfer | 1 | 2004 | 47 | 0.220 |
Why?
| | Crystallization | 1 | 2004 | 136 | 0.220 |
Why?
| | Animals, Newborn | 5 | 2016 | 777 | 0.210 |
Why?
| | Radiographic Image Interpretation, Computer-Assisted | 1 | 2004 | 98 | 0.210 |
Why?
| | Nanotechnology | 1 | 2004 | 113 | 0.200 |
Why?
| | Hydrogels | 3 | 2022 | 573 | 0.200 |
Why?
| | Echocardiography | 2 | 2005 | 569 | 0.200 |
Why?
| | Ventricular Dysfunction, Left | 1 | 2006 | 371 | 0.200 |
Why?
| | Biomechanical Phenomena | 4 | 2013 | 669 | 0.200 |
Why?
| | Aortic Coarctation | 1 | 2003 | 70 | 0.200 |
Why?
| | Coronary Angiography | 1 | 2004 | 308 | 0.190 |
Why?
| | Neovascularization, Physiologic | 2 | 2020 | 174 | 0.190 |
Why?
| | Muscle, Smooth, Vascular | 2 | 2017 | 409 | 0.180 |
Why?
| | Acrylamides | 2 | 2018 | 42 | 0.180 |
Why?
| | Case-Control Studies | 5 | 2017 | 3007 | 0.180 |
Why?
| | Adolescent | 12 | 2017 | 17811 | 0.180 |
Why?
| | Cardiac Catheterization | 4 | 2015 | 545 | 0.180 |
Why?
| | Hypertension | 1 | 2008 | 1052 | 0.170 |
Why?
| | Delayed-Action Preparations | 2 | 2018 | 158 | 0.170 |
Why?
| | Infant | 8 | 2015 | 7946 | 0.170 |
Why?
| | Regional Blood Flow | 6 | 2013 | 421 | 0.170 |
Why?
| | Equipment Design | 4 | 2014 | 503 | 0.170 |
Why?
| | Vena Cava, Inferior | 3 | 2006 | 56 | 0.160 |
Why?
| | Temperature | 3 | 2014 | 564 | 0.160 |
Why?
| | Models, Statistical | 3 | 2015 | 595 | 0.160 |
Why?
| | Biomimetic Materials | 2 | 2017 | 64 | 0.160 |
Why?
| | Particle Size | 4 | 2013 | 317 | 0.160 |
Why?
| | Ultrasonography, Doppler, Color | 2 | 2010 | 33 | 0.160 |
Why?
| | Echocardiography, Three-Dimensional | 1 | 1999 | 49 | 0.150 |
Why?
| | Angiogenesis Inducing Agents | 1 | 2018 | 21 | 0.150 |
Why?
| | Metal Nanoparticles | 1 | 2019 | 69 | 0.150 |
Why?
| | Gold | 1 | 2019 | 102 | 0.150 |
Why?
| | Myocardial Infarction | 2 | 2022 | 932 | 0.150 |
Why?
| | Sulfones | 1 | 2018 | 97 | 0.150 |
Why?
| | Pulmonary Wedge Pressure | 2 | 2009 | 64 | 0.150 |
Why?
| | Heart Valve Diseases | 1 | 1999 | 162 | 0.140 |
Why?
| | Bronchoscopy | 1 | 2018 | 196 | 0.140 |
Why?
| | Nanotubes, Carbon | 1 | 2017 | 42 | 0.140 |
Why?
| | Computer-Aided Design | 2 | 2009 | 38 | 0.140 |
Why?
| | Finite Element Analysis | 3 | 2007 | 66 | 0.130 |
Why?
| | Disease Models, Animal | 3 | 2011 | 3499 | 0.130 |
Why?
| | Cardiac Output | 1 | 2016 | 143 | 0.130 |
Why?
| | Laminin | 1 | 2016 | 69 | 0.130 |
Why?
| | Endothelial Cells | 2 | 2012 | 677 | 0.130 |
Why?
| | Biomimetics | 1 | 2016 | 36 | 0.130 |
Why?
| | Echinococcosis, Pulmonary | 1 | 2015 | 5 | 0.130 |
Why?
| | Embryonic Stem Cells | 1 | 2016 | 106 | 0.120 |
Why?
| | Drug Carriers | 2 | 2013 | 112 | 0.120 |
Why?
| | Acoustics | 2 | 2006 | 46 | 0.120 |
Why?
| | Pilot Projects | 2 | 2011 | 1361 | 0.120 |
Why?
| | Arterial Pressure | 1 | 2015 | 99 | 0.120 |
Why?
| | Severity of Illness Index | 4 | 2017 | 2540 | 0.120 |
Why?
| | Fibroblasts | 1 | 2019 | 836 | 0.120 |
Why?
| | Serum Albumin, Bovine | 1 | 2014 | 60 | 0.120 |
Why?
| | Bronchi | 1 | 2015 | 223 | 0.120 |
Why?
| | Familial Primary Pulmonary Hypertension | 2 | 2013 | 191 | 0.110 |
Why?
| | Magnetic Resonance Angiography | 1 | 2016 | 221 | 0.110 |
Why?
| | Lysine | 1 | 2016 | 241 | 0.110 |
Why?
| | Myocardium | 1 | 2019 | 911 | 0.110 |
Why?
| | Feasibility Studies | 4 | 2015 | 735 | 0.110 |
Why?
| | Airway Extubation | 1 | 2014 | 43 | 0.110 |
Why?
| | Stearic Acids | 1 | 2013 | 12 | 0.110 |
Why?
| | Polyethyleneimine | 1 | 2013 | 18 | 0.110 |
Why?
| | Cells, Cultured | 7 | 2017 | 3862 | 0.110 |
Why?
| | Portal Vein | 1 | 2014 | 75 | 0.110 |
Why?
| | Heparin | 1 | 2014 | 225 | 0.110 |
Why?
| | Phonophoresis | 1 | 2013 | 1 | 0.110 |
Why?
| | Microfluidic Analytical Techniques | 1 | 2013 | 70 | 0.110 |
Why?
| | Time Factors | 4 | 2015 | 6077 | 0.100 |
Why?
| | Silicon Dioxide | 1 | 2013 | 89 | 0.100 |
Why?
| | Tensile Strength | 1 | 2013 | 88 | 0.100 |
Why?
| | Herniorrhaphy | 1 | 2013 | 47 | 0.100 |
Why?
| | Vena Cava, Superior | 2 | 2003 | 23 | 0.100 |
Why?
| | Microspheres | 2 | 2006 | 123 | 0.100 |
Why?
| | Collagen | 2 | 2012 | 414 | 0.100 |
Why?
| | Industry | 1 | 2013 | 65 | 0.100 |
Why?
| | Cell Separation | 1 | 2013 | 290 | 0.100 |
Why?
| | Intubation, Intratracheal | 1 | 2014 | 214 | 0.100 |
Why?
| | Neural Stem Cells | 1 | 2013 | 113 | 0.100 |
Why?
| | Tetraspanin 28 | 1 | 2012 | 4 | 0.100 |
Why?
| | Coronary Vessels | 2 | 2004 | 234 | 0.100 |
Why?
| | Paclitaxel | 1 | 2013 | 190 | 0.100 |
Why?
| | Sutures | 1 | 2012 | 50 | 0.100 |
Why?
| | Structure-Activity Relationship | 2 | 2013 | 499 | 0.100 |
Why?
| | Antineoplastic Agents, Phytogenic | 1 | 2013 | 182 | 0.090 |
Why?
| | Elastic Tissue | 1 | 2011 | 8 | 0.090 |
Why?
| | Diagnostic Imaging | 1 | 2014 | 278 | 0.090 |
Why?
| | Fibrillar Collagens | 1 | 2011 | 12 | 0.090 |
Why?
| | Ophthalmologic Surgical Procedures | 1 | 2012 | 55 | 0.090 |
Why?
| | Transfection | 1 | 2013 | 863 | 0.090 |
Why?
| | Predictive Value of Tests | 3 | 2015 | 1791 | 0.090 |
Why?
| | Models, Animal | 1 | 2013 | 340 | 0.090 |
Why?
| | Suture Techniques | 1 | 2012 | 115 | 0.090 |
Why?
| | Angiogenesis Inhibitors | 1 | 2013 | 213 | 0.090 |
Why?
| | Oscillometry | 2 | 2013 | 33 | 0.090 |
Why?
| | Pressure | 3 | 2014 | 214 | 0.090 |
Why?
| | Swine | 1 | 2013 | 687 | 0.090 |
Why?
| | Arthroplasty | 1 | 2010 | 48 | 0.090 |
Why?
| | Intervertebral Disc Displacement | 1 | 2010 | 37 | 0.090 |
Why?
| | Mice | 8 | 2022 | 14847 | 0.090 |
Why?
| | Equipment Failure | 1 | 2010 | 107 | 0.090 |
Why?
| | Species Specificity | 1 | 2011 | 541 | 0.090 |
Why?
| | Lipids | 1 | 2013 | 564 | 0.090 |
Why?
| | Cell Membrane | 1 | 2013 | 670 | 0.090 |
Why?
| | Flow Cytometry | 1 | 2013 | 1075 | 0.090 |
Why?
| | Middle Aged | 4 | 2018 | 26621 | 0.080 |
Why?
| | Nanoparticles | 1 | 2013 | 312 | 0.080 |
Why?
| | Coculture Techniques | 3 | 2019 | 198 | 0.080 |
Why?
| | Central Venous Pressure | 1 | 2009 | 12 | 0.080 |
Why?
| | Viscosity | 1 | 2009 | 81 | 0.080 |
Why?
| | Electric Capacitance | 1 | 2009 | 7 | 0.080 |
Why?
| | Endothelial Growth Factors | 1 | 2009 | 49 | 0.080 |
Why?
| | Prostheses and Implants | 1 | 2010 | 135 | 0.080 |
Why?
| | Prosthesis Implantation | 1 | 2010 | 138 | 0.080 |
Why?
| | Antibodies, Monoclonal, Humanized | 1 | 2013 | 660 | 0.080 |
Why?
| | Internship and Residency | 1 | 2018 | 920 | 0.080 |
Why?
| | Echocardiography, Doppler, Color | 2 | 2000 | 41 | 0.080 |
Why?
| | Stress, Physiological | 1 | 2012 | 379 | 0.080 |
Why?
| | Vasoconstrictor Agents | 1 | 2009 | 113 | 0.080 |
Why?
| | Hyperbaric Oxygenation | 1 | 2008 | 36 | 0.080 |
Why?
| | Atherosclerosis | 1 | 2012 | 342 | 0.080 |
Why?
| | Prosthesis Design | 2 | 2007 | 283 | 0.080 |
Why?
| | Cell Adhesion Molecules | 1 | 2009 | 167 | 0.070 |
Why?
| | Logistic Models | 2 | 2015 | 1830 | 0.070 |
Why?
| | Reference Standards | 1 | 2008 | 159 | 0.070 |
Why?
| | Tunica Media | 1 | 2007 | 35 | 0.070 |
Why?
| | Electric Impedance | 1 | 2007 | 100 | 0.070 |
Why?
| | Tunica Intima | 1 | 2007 | 78 | 0.070 |
Why?
| | Aortic Aneurysm, Abdominal | 1 | 2008 | 113 | 0.070 |
Why?
| | DNA | 1 | 2013 | 1350 | 0.070 |
Why?
| | Signal Processing, Computer-Assisted | 1 | 2007 | 131 | 0.070 |
Why?
| | Probability | 1 | 2007 | 286 | 0.070 |
Why?
| | Endothelium, Vascular | 2 | 2012 | 830 | 0.070 |
Why?
| | Cell Differentiation | 1 | 2013 | 1696 | 0.070 |
Why?
| | Prospective Studies | 1 | 2017 | 6198 | 0.070 |
Why?
| | Blood Vessel Prosthesis | 1 | 2007 | 113 | 0.070 |
Why?
| | Hemolysis | 1 | 2006 | 143 | 0.060 |
Why?
| | Nanotubes | 1 | 2006 | 41 | 0.060 |
Why?
| | Protein Conformation | 1 | 2008 | 803 | 0.060 |
Why?
| | Venae Cavae | 1 | 2005 | 9 | 0.060 |
Why?
| | Aortic Valve Stenosis | 2 | 1999 | 269 | 0.060 |
Why?
| | Adaptation, Physiological | 1 | 2008 | 484 | 0.060 |
Why?
| | Radiography | 1 | 2007 | 803 | 0.060 |
Why?
| | Research Design | 1 | 2010 | 919 | 0.060 |
Why?
| | Surgery, Computer-Assisted | 1 | 2005 | 61 | 0.060 |
Why?
| | ROC Curve | 2 | 2015 | 441 | 0.060 |
Why?
| | Computing Methodologies | 1 | 2004 | 2 | 0.060 |
Why?
| | Manufactured Materials | 1 | 2004 | 4 | 0.060 |
Why?
| | Anatomy, Cross-Sectional | 1 | 2004 | 11 | 0.060 |
Why?
| | Chronic Disease | 1 | 2010 | 1579 | 0.060 |
Why?
| | Tomography, X-Ray Computed | 1 | 2013 | 2273 | 0.060 |
Why?
| | Rats, Long-Evans | 1 | 2004 | 98 | 0.050 |
Why?
| | Quality Control | 1 | 2004 | 143 | 0.050 |
Why?
| | Motion | 1 | 2004 | 92 | 0.050 |
Why?
| | Mitral Valve | 1 | 2004 | 94 | 0.050 |
Why?
| | Antineoplastic Agents | 1 | 2013 | 1875 | 0.050 |
Why?
| | Dogs | 1 | 2004 | 331 | 0.050 |
Why?
| | Breast Neoplasms | 1 | 2013 | 1846 | 0.050 |
Why?
| | Heart | 1 | 2006 | 613 | 0.050 |
Why?
| | Ultrasonography, Interventional | 1 | 2002 | 120 | 0.050 |
Why?
| | Pediatrics | 2 | 2006 | 981 | 0.050 |
Why?
| | RNA, Messenger | 1 | 2009 | 2550 | 0.050 |
Why?
| | Cytokines | 1 | 2009 | 1824 | 0.050 |
Why?
| | Retrospective Studies | 3 | 2015 | 12521 | 0.050 |
Why?
| | Risk Factors | 2 | 2015 | 8612 | 0.050 |
Why?
| | Binomial Distribution | 1 | 2000 | 4 | 0.040 |
Why?
| | Interleukin-10 | 1 | 2022 | 293 | 0.040 |
Why?
| | Cell Survival | 2 | 2013 | 1014 | 0.040 |
Why?
| | Mechanotransduction, Cellular | 2 | 2012 | 97 | 0.040 |
Why?
| | Myosin Heavy Chains | 2 | 2012 | 178 | 0.040 |
Why?
| | Platelet-Derived Growth Factor | 1 | 2020 | 80 | 0.040 |
Why?
| | Human Umbilical Vein Endothelial Cells | 1 | 2020 | 88 | 0.040 |
Why?
| | Albumins | 1 | 1999 | 89 | 0.040 |
Why?
| | Actins | 2 | 2012 | 376 | 0.040 |
Why?
| | Prognosis | 2 | 2017 | 3315 | 0.040 |
Why?
| | Cell Line | 2 | 2014 | 2629 | 0.040 |
Why?
| | Formative Feedback | 1 | 2018 | 22 | 0.040 |
Why?
| | Injections, Subcutaneous | 1 | 2018 | 134 | 0.040 |
Why?
| | Mitral Valve Stenosis | 1 | 1998 | 22 | 0.040 |
Why?
| | Age Factors | 2 | 2015 | 2886 | 0.040 |
Why?
| | Gelatin | 1 | 2017 | 36 | 0.040 |
Why?
| | Young Adult | 3 | 2015 | 10459 | 0.030 |
Why?
| | Aging | 1 | 2005 | 1612 | 0.030 |
Why?
| | Principal Component Analysis | 1 | 2015 | 177 | 0.030 |
Why?
| | Demography | 1 | 2015 | 258 | 0.030 |
Why?
| | Sulfonic Acids | 1 | 2014 | 12 | 0.030 |
Why?
| | Area Under Curve | 1 | 2015 | 273 | 0.030 |
Why?
| | Proton Magnetic Resonance Spectroscopy | 1 | 2014 | 20 | 0.030 |
Why?
| | Phase Transition | 1 | 2014 | 25 | 0.030 |
Why?
| | Constriction, Pathologic | 3 | 2000 | 207 | 0.030 |
Why?
| | Manikins | 1 | 2014 | 23 | 0.030 |
Why?
| | Spectroscopy, Fourier Transform Infrared | 1 | 2014 | 76 | 0.030 |
Why?
| | Cell Proliferation | 2 | 2013 | 2173 | 0.030 |
Why?
| | Circular Dichroism | 1 | 2014 | 135 | 0.030 |
Why?
| | Static Electricity | 1 | 2014 | 112 | 0.030 |
Why?
| | Microscopy, Electron, Scanning | 1 | 2014 | 192 | 0.030 |
Why?
| | Patient Positioning | 1 | 2014 | 41 | 0.030 |
Why?
| | Cardiography, Impedance | 1 | 2013 | 6 | 0.030 |
Why?
| | Myocardial Contraction | 1 | 2015 | 318 | 0.030 |
Why?
| | Adhesiveness | 1 | 2013 | 19 | 0.030 |
Why?
| | Luciferases, Firefly | 1 | 2013 | 3 | 0.030 |
Why?
| | Adult | 3 | 2010 | 30395 | 0.030 |
Why?
| | Head | 1 | 2014 | 85 | 0.030 |
Why?
| | Airway Management | 1 | 2014 | 59 | 0.030 |
Why?
| | Porosity | 1 | 2013 | 88 | 0.030 |
Why?
| | MCF-7 Cells | 1 | 2013 | 105 | 0.030 |
Why?
| | Trastuzumab | 1 | 2013 | 89 | 0.030 |
Why?
| | Sonication | 1 | 2013 | 10 | 0.030 |
Why?
| | Cell Death | 1 | 2014 | 322 | 0.030 |
Why?
| | Drug Screening Assays, Antitumor | 1 | 2013 | 181 | 0.030 |
Why?
| | Survival Rate | 1 | 2017 | 1638 | 0.030 |
Why?
| | Ramipril | 1 | 2012 | 4 | 0.030 |
Why?
| | Treatment Outcome | 4 | 2013 | 9051 | 0.030 |
Why?
| | Quantum Dots | 1 | 2013 | 34 | 0.030 |
Why?
| | Peptidyl-Dipeptidase A | 1 | 2012 | 51 | 0.030 |
Why?
| | Plasmids | 1 | 2013 | 343 | 0.030 |
Why?
| | Hypertrophy | 1 | 2012 | 110 | 0.030 |
Why?
| | Drug Compounding | 1 | 2013 | 89 | 0.030 |
Why?
| | Surface Properties | 1 | 2013 | 385 | 0.030 |
Why?
| | Solubility | 1 | 2013 | 223 | 0.020 |
Why?
| | Methylphenazonium Methosulfate | 1 | 2012 | 1 | 0.020 |
Why?
| | Tumor Cells, Cultured | 1 | 2013 | 845 | 0.020 |
Why?
| | Clinical Competence | 1 | 2018 | 882 | 0.020 |
Why?
| | Hyaluronic Acid | 1 | 2013 | 189 | 0.020 |
Why?
| | Liposomes | 1 | 2013 | 146 | 0.020 |
Why?
| | Transforming Growth Factor beta1 | 1 | 2012 | 153 | 0.020 |
Why?
| | Microcirculation | 1 | 2012 | 133 | 0.020 |
Why?
| | Statistics, Nonparametric | 1 | 2012 | 384 | 0.020 |
Why?
| | Vasodilation | 1 | 2013 | 418 | 0.020 |
Why?
| | Xenograft Model Antitumor Assays | 1 | 2013 | 695 | 0.020 |
Why?
| | Immunohistochemistry | 1 | 2014 | 1624 | 0.020 |
Why?
| | Mice, Inbred BALB C | 1 | 2013 | 1144 | 0.020 |
Why?
| | Software | 1 | 2013 | 526 | 0.020 |
Why?
| | Thromboxane B2 | 1 | 2009 | 26 | 0.020 |
Why?
| | Prostaglandins F | 1 | 2009 | 17 | 0.020 |
Why?
| | Inflammation | 1 | 2020 | 2465 | 0.020 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2013 | 1837 | 0.020 |
Why?
| | Hypoxanthine Phosphoribosyltransferase | 1 | 2009 | 24 | 0.020 |
Why?
| | Mice, Inbred C57BL | 1 | 2018 | 4682 | 0.020 |
Why?
| | Blotting, Western | 1 | 2012 | 1143 | 0.020 |
Why?
| | Sulfonamides | 1 | 2012 | 444 | 0.020 |
Why?
| | E-Selectin | 1 | 2009 | 52 | 0.020 |
Why?
| | Chemokine CCL2 | 1 | 2009 | 104 | 0.020 |
Why?
| | Polyethylene Glycols | 1 | 2013 | 561 | 0.020 |
Why?
| | Nitric Oxide Synthase Type III | 1 | 2009 | 181 | 0.020 |
Why?
| | Cadherins | 1 | 2009 | 175 | 0.020 |
Why?
| | Endothelin-1 | 1 | 2009 | 168 | 0.020 |
Why?
| | Extracellular Matrix | 1 | 2011 | 436 | 0.020 |
Why?
| | Transcriptional Activation | 1 | 2009 | 337 | 0.020 |
Why?
| | Proto-Oncogene Proteins c-akt | 1 | 2009 | 397 | 0.020 |
Why?
| | Acrylates | 1 | 2007 | 45 | 0.020 |
Why?
| | Antigens, CD | 1 | 2009 | 440 | 0.020 |
Why?
| | Cell Line, Tumor | 1 | 2013 | 2699 | 0.020 |
Why?
| | Analysis of Variance | 1 | 2009 | 1218 | 0.020 |
Why?
| | Up-Regulation | 1 | 2009 | 802 | 0.020 |
Why?
| | Phosphorylation | 1 | 2009 | 1559 | 0.020 |
Why?
| | Disease Progression | 1 | 2012 | 2371 | 0.010 |
Why?
| | Nitric Oxide | 1 | 2009 | 817 | 0.010 |
Why?
| | Gene Expression | 1 | 2009 | 1417 | 0.010 |
Why?
| | Apoptosis | 1 | 2013 | 2349 | 0.010 |
Why?
| | Stents | 1 | 2007 | 466 | 0.010 |
Why?
| | Regression Analysis | 1 | 2005 | 945 | 0.010 |
Why?
| | Monitoring, Intraoperative | 1 | 2002 | 38 | 0.010 |
Why?
| | Anastomosis, Surgical | 1 | 2002 | 135 | 0.010 |
Why?
| | Angioplasty, Balloon | 1 | 1999 | 89 | 0.010 |
Why?
| | Veins | 1 | 1998 | 55 | 0.010 |
Why?
| | Cohort Studies | 1 | 2005 | 4885 | 0.010 |
Why?
| | Postoperative Complications | 1 | 2002 | 2122 | 0.010 |
Why?
| | Aged | 1 | 2005 | 18973 | 0.000 |
Why?
|
|
Shandas's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|